Wave Life Sciences to Present at Upcoming Investor Conferences
March 27 2024 - 8:30AM
Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage
biotechnology company focused on unlocking the broad potential of
RNA medicines to transform human health, today announced that Paul
Bolno, MD, MBA, President and Chief Executive Officer, is scheduled
to participate in two upcoming investor conferences in April.
Cantor Virtual Muscular Dystrophy Symposium
Date: Wednesday, April 3, 2024Analyst-led fireside chat
presentation time: 3:10 p.m. ET
23rd Annual Needham Virtual Healthcare
Conference Date: Thursday, April 11, 2024Company
presentation time: 8:45 a.m. ET
Live webcasts of these presentations will be available on the
Investor Relations page of the Wave Life Sciences website at
http://ir.wavelifesciences.com. Replays of these presentations will
be archived and available on the site for a limited time following
the event.
About Wave Life SciencesWave Life Sciences
(Nasdaq: WVE) is a biotechnology company focused on unlocking the
broad potential of RNA medicines to transform human health. Wave’s
RNA medicines platform, PRISM™, combines multiple modalities,
chemistry innovation and deep insights in human genetics to deliver
scientific breakthroughs that treat both rare and prevalent
disorders. Its toolkit of RNA-targeting modalities includes
editing, splicing, RNA interference and antisense silencing,
providing Wave with unmatched capabilities for designing and
sustainably delivering candidates that optimally address disease
biology. Wave’s diversified pipeline includes clinical programs in
Duchenne muscular dystrophy, Alpha-1 antitrypsin deficiency and
Huntington’s disease, as well as a preclinical program in obesity.
Driven by the calling to “Reimagine Possible”, Wave is leading the
charge toward a world in which human potential is no longer
hindered by the burden of disease. Wave is headquartered in
Cambridge, MA. For more information on Wave’s science, pipeline and
people, please visit www.wavelifesciences.com and follow Wave on X
(formerly Twitter) and LinkedIn.
Investor Contact:Kate Rausch+1
617-949-4827krausch@wavelifesci.com
Media Contact:Alicia Suter+1
617-949-4817asuter@wavelifesci.com
Wave Life Sciences (NASDAQ:WVE)
Historical Stock Chart
From Sep 2024 to Oct 2024
Wave Life Sciences (NASDAQ:WVE)
Historical Stock Chart
From Oct 2023 to Oct 2024